PROCENA KVALITETA ŽIVOTA POVEZANOG SA ZDRAVLJEM KOD PACIJENATA ZARAŽENIH VIRUSOM COVID-19 PRE INFEKCIJE I TRI MESECA NAKON OTPUSTA SA BOLNIČKOG LEČENJA
Sažetak
Infektivno oboljenje COVID-19, izazvano SARS-CoV-2 virusom, i dalje predstavlja značajnu globalnu pretnju po zdravlje ljudi. Pored toga što ovo oboljenje nesumnjivo utiče na fizičko zdravlje, postoje i dokazi o njegovom ozbiljnom uticaju na mentalno zdravlje.
Naše istraživanje imalo je za cilj da proceni promene u kvalitetu života kod obolelih od COVID-19 pre hospitalizacije i tri meseca nakon otpusta iz bolnice.
Podaci su dobijeni od 70 ispitanika sa postavljenom dijagnozom COVID-19 koji su bili hospitalizovani na Klinici za infektivne bolesti Univerzitetskog kliničkog centra u Nišu. Bili su ispitani dva puta: nakon prijema na bolničko lečenje i tri meseca nakon otpusta. Kvalitet života meren je na osnovu sledećih upitnika: 36-item Short Form Survey (SF-36), Pittsburgh Sleep Quality Index (PSQI), Patient Health Questionnaire-9 (PHQ9) i Generalized Anxiety Disorder 7-item (GAD-7). Statistička značajnost dveju promenljivih merena u istom uzorku u dva različita trenutka poređena je uz pomoć uparenog T-testa.
Postojala je statistički značajna razlika u PHQ9 skorovima pre hospitalizacije i posle nje (t = 4,738; p < 0,01). Nije bilo značajne promene PSQI skora pre hospitalizacije i tri meseca nakon otpusta (t = -0.622; p = 536). Naši rezultati pokazali su statistički značajan porast GAD7 i značajan pad skora komponente fizičkog funkcionisanja (engl. phisical functioning – PF) (t = 5,929; p < 0,01), kao i skora komponente ograničenja zbog fizičkih zdravstvenih problema (engl. emotional regulation – RP) (t = 4,385; p < 0,01). Prema dobijenim rezultatima, nije bilo statistički značajne razlike između perioda pre infekcije i perioda nakon otpusta iz bolnice u komponentama SF-36 upitnika koje se odnose na ograničenja usled emocionalnih problema i na domen socijalnog funkcionisanja (engl. social functioning – SF).
Na osnovu rezultata našeg istraživanja može se zaključiti da oboleli od COVID-19 imaju fizičke i mentalne zdravstvene probleme koji mogu trajati i nakon oporavka od infekcije i negativno uticati na kvalitet života.
Reference
Busija L, Osborne RH, Nilsdotter A, Buchbinder R, Roos EM. Magnitude and meaningfulness of change in SF-36 scores in four types of orthopedic surgery. Health Qual Life Outcomes 2008;6:55. [CrossRef] [PubMed]
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28(2):193-213. [CrossRef] [PubMed]
Chandra SS, Loganathan K, Awuzie BO, Wang F. A Longitudinal Study Examining the Association between Cognitive Behavior and Rational Abilities and the Effect of Sleep Quality on Construction Laborers. Sustainability 2023; 15(7):6257. [CrossRef]
Chen KY, Li T, Gong FH, Zhang JS, Li XK. Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month. Front Psychiatry 2020; 11:668. [CrossRef] [PubMed]
Gupta PK, Singh S, Mahour P, Gupta B, Agarwal M, Dalal PK, et al. Mental health outcome in hospitalized COVID-19 patients: An observational analysis from North Indian tertiary care hospital. Clin Epidemiol Glob Health 2023; 19:101209. [CrossRef] [PubMed]
Holmes EA, O'Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 2020;7(6):547-60. [CrossRef] [PubMed]
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397(10270):220–32. [CrossRef] [PubMed]
Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 2021; 131:105295. [CrossRef] [PubMed]
Kar N, Kar B, Kar S. Stress and coping during COVID-19 pandemic: Result of an online survey. Psychiatry Res 2021; 295:113598. [CrossRef] [PubMed]
Khraisat B, Toubasi A, AlZoubi L, Al-Sayegh T, Mansour A. Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors. Int J Psychiatry Clin Pract 2022; 26(3):234-43. [CrossRef] [PubMed]
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606-13. [CrossRef] [PubMed]
Lam MH, Wing YK, Yu MW, Leung CM, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med 2009;169(22):2142-7. [CrossRef] [PubMed]
Li D, Liao X, Ma Z, Zhang L, Dong J, Zheng G, et al. Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study. Ann Intensive Care 2022; 12(1): 64. [CrossRef] [PubMed]
Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med 2016;4;4: 2050312116671725. [CrossRef] [PubMed]
Liu D, Baumeister RF, Veilleux JC, Chen C, Liu W, Yue Y, et al. Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Res 2020; 292:113297. [CrossRef] [PubMed]
Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun 2020; 89: 594-600. [CrossRef] [PubMed]
McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31(3):247-63. [CrossRef] [PubMed]
Putri C, Arisa J, Hananto JE, Hariyanto TI, Kurniawan A. Psychiatric sequelae in COVID-19 survivors: A narrative review. World J Psychiatry 2021;11(10):821-9. [CrossRef] [PubMed]
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020;7(7):611-27. [CrossRef] [PubMed]
Şahin H, Yıldırım A, Hacıhasanoğlu Aşılar R, Çebi K, Güneş D. The relationship between nutritional behaviours and sleep quality in individuals applying to primary healthcare organizations. J Turk Sleep Med 2020; 7: 29–39. [CrossRef]
Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review. Brain Behav Immun (2021) 97:328–48. [CrossRef] [PubMed]
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166(10): 1092-7. [CrossRef] [PubMed]
Szcześniak D, Gładka A, Misiak B, Cyran A, Rymaszewska J. The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Prog Neuropsychopharmacol Biol Psychiatry 2021; 104:110046. [CrossRef] [PubMed]
Tarsitani L, Vassalini P, Koukopoulos A,Borrazzo C, Alessi F, di Nicolantonio C, et al. Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge. J Gen Intern Med 2021;36(6):1702-7. [CrossRef] [PubMed]
Wang C, Pan R, Wan X, Tan Y, Xu L, Mclntyre RS, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun 2020; 87:40-8. [CrossRef] [PubMed]
Wei Y, Blanken TF, Van Someren EJW. Insomnia really hurts: effect of a bad night’s sleep on pain increases with insomnia severity. Front Psychiatry 2019; 9: 377. [CrossRef] [PubMed]
Wu C, Hu X, Song J, Yang D, Xu J, Cheng K, et al. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China. Clin Transl Med 2020;10(2):e52. [CrossRef] [PubMed]
Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Pham L, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord 2020; 277:55-64. [CrossRef] [PubMed]
